Fintech Festival and the Singapore Week of Innovation and Technology to feature world’s 24-hour hybrid digital and physical event
GlobeNewswire
Global Biopharmaceutical Logistics Industry
Global Biopharmaceutical Logistics Market to Reach $109. 7 Billion by 2027. Amid the COVID-19 crisis, the global market for Biopharmaceutical Logistics estimated at US$78. 8 Billion in the year 2020, is projected to reach a revised size of US$109.New York, Dec. 02, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Biopharmaceutical Logistics Industry” – https://www.reportlinker.com/p05960814/?utm_source=GNW 7 Billion by 2027, growing at aCAGR of 4.8% over the period 2020-2027. Cold Chain Logistics, one of the segments analyzed in the report, is projected to record 5.3% CAGR and reach US$29.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-cold Chain Logistics segment is readjusted to a revised 4.7% CAGR for the next 7-year period. The U.S. Market is Estimated at $23.2 Billion, While China is Forecast to Grow at 4.5% CAGR The Biopharmaceutical Logistics market in the U.S. is estimated at US$23.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$19.4 Billion by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 3.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.We bring years of research experience to this 7th edition of our report. The 170-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Competitors identified in this market include, among others, * AmerisourceBergen Corporation * DB Schenker * DHL Express Germany GmbH * FedEx Corporation * United Parcel Service, Inc. (UPS) Read the full report: https://www.reportlinker.com/p05960814/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Biopharmaceutical Logistics Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Biopharmaceutical Logistics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 2: World Historic Review for Biopharmaceutical Logistics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 3: World 15-Year Perspective for Biopharmaceutical Logistics by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Cold Chain Logistics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 5: World Historic Review for Cold Chain Logistics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 6: World 15-Year Perspective for Cold Chain Logistics by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Non-cold Chain Logistics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 8: World Historic Review for Non-cold Chain Logistics by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 9: World 15-Year Perspective for Non-cold Chain Logistics by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for Transportation by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 11: World Historic Review for Transportation by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 12: World 15-Year Perspective for Transportation by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for Warehousing by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 14: World Historic Review for Warehousing by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 15: World 15-Year Perspective for Warehousing by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Biopharmaceutical Logistics Market Share (in %) by Company: 2019 & 2025 Market Analytics Table 16: USA Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 17: USA Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 18: USA 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 19: USA Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 20: USA Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 21: USA 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 CANADA Table 22: Canada Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 23: Canada Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 24: Canada 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 25: Canada Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 26: Canada Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 27: Canada 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 JAPAN Table 28: Japan Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 29: Japan Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 30: Japan 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 31: Japan Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 32: Japan Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 33: Japan 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 CHINA Table 34: China Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 35: China Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 36: China 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 37: China Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 38: China Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 39: China 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 EUROPE Market Facts & Figures European Biopharmaceutical Logistics Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Market Analytics Table 40: Europe Current & Future Analysis for Biopharmaceutical Logistics by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 Table 41: Europe Historic Review for Biopharmaceutical Logistics by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 42: Europe 15-Year Perspective for Biopharmaceutical Logistics by Geographic Region – Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 43: Europe Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 44: Europe Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 45: Europe 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 46: Europe Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 47: Europe Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 48: Europe 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 FRANCE Table 49: France Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 50: France Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 51: France 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 52: France Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 53: France Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 54: France 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 GERMANY Table 55: Germany Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 56: Germany Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 57: Germany 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 58: Germany Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 59: Germany Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 60: Germany 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 ITALY Table 61: Italy Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 62: Italy Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 63: Italy 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 64: Italy Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 65: Italy Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 66: Italy 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 67: UK Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 68: UK Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 69: UK 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 70: UK Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 71: UK Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 72: UK 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 REST OF EUROPE Table 73: Rest of Europe Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 74: Rest of Europe Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 75: Rest of Europe 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 76: Rest of Europe Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 77: Rest of Europe Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 78: Rest of Europe 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 ASIA-PACIFIC Table 79: Asia-Pacific Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 80: Asia-Pacific Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 81: Asia-Pacific 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 82: Asia-Pacific Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 83: Asia-Pacific Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 84: Asia-Pacific 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 REST OF WORLD Table 85: Rest of World Current & Future Analysis for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 86: Rest of World Historic Review for Biopharmaceutical Logistics by Type – Cold Chain Logistics and Non-cold Chain Logistics Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 87: Rest of World 15-Year Perspective for Biopharmaceutical Logistics by Type – Percentage Breakdown of Value Sales for Cold Chain Logistics and Non-cold Chain Logistics for the Years 2012, 2020 & 2027 Table 88: Rest of World Current & Future Analysis for Biopharmaceutical Logistics by Service – Transportation and Warehousing – Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 Table 89: Rest of World Historic Review for Biopharmaceutical Logistics by Service – Transportation and Warehousing Markets – Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 Table 90: Rest of World 15-Year Perspective for Biopharmaceutical Logistics by Service – Percentage Breakdown of Value Sales for Transportation and Warehousing for the Years 2012, 2020 & 2027 IV. COMPETITION Total Companies Profiled: 41 Read the full report: https://www.reportlinker.com/p05960814/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place. __________________________ CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
Original Source
CryptoCurrency | USD | Change 1h | Change 24h | Change 7d |
---|---|---|---|---|
Bitcoin | 1.19 % | 5.71 % | 13.39 % | |
Ethereum | 1.69 % | 2.45 % | 9.76 % | |
Tether | 0.39 % | 0.27 % | 0.12 % | |
Polkadot | 0.57 % | 8.92 % | 49.46 % | |
XRP | 1.06 % | 0.28 % | 7.39 % | |
Cardano | 0.85 % | 0.98 % | 10.66 % | |
Litecoin | 1.12 % | 5.12 % | 8.26 % | |
Bitcoin Cash | 1.75 % | 6.44 % | 9.85 % | |
Chainlink | 1.47 % | 0.26 % | 23.32 % | |
Stellar | 0.60 % | 3.06 % | 9.61 % | |
Binance Coin | 1.54 % | 2.42 % | 0.90 % | |
USD Coin | 0.55 % | 0.09 % | 0.06 % | |
Wrapped Bitcoin | 1.19 % | 5.03 % | 12.70 % | |
Bitcoin SV | 1.25 % | 0.25 % | 11.39 % | |
Monero | 1.05 % | 4.68 % | 17.44 % | |
EOS | 1.52 % | 3.00 % | 5.29 % | |
VeChain | 0.50 % | 2.84 % | 22.72 % | |
Aave | 1.86 % | 4.46 % | 14.78 % | |
TRON | 0.80 % | 1.89 % | 3.77 % | |
Tezos | 0.62 % | 2.93 % | 6.43 % |